eflapegrastim
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for eflapegrastim, covering 2024-09-19 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy [Phase 2]